This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Global Pharmaceutical Regulatory Affairs Summit
22-24 October 2024
Sheraton Brussels Airport, BrusselsHybrid Event

Kwee-Lan Tan
Regional Regulatory Lead, Emerging Markets at Boehringer Ingelheim
Speaker

Profile

Kwee Lan Tan is the Head of the Regional Regulatory Lead Emerging Markets team at Boehringer Ingelheim International GmbH. In this role, she leads a team of Regional Regulatory Leads responsible for the therapeutic areas of inflammation and oncology. Over the past three years, she has actively engaged with various regulatory authorities, successfully driving the registration of new drug applications with Orphan drug designation.

Before her international role in Germany, Kwee Lan held the position of Head of Regulatory Affairs for Malaysia and Singapore in 2017. During her tenure, she established strong collaborations with local industry associations and health authorities, which included organizing workshops on disease education and shaping local regulations and policies.

In addition to her regulatory experience, Kwee Lan began her career in pharmacovigilance activities at Pfizer and Boehringer Ingelheim. Kwee Lan holds a Degree in Biotechnology and has 13 years of experience in the pharmaceutical industry.

Agenda Sessions

  • Transforming Challenges into Opportunities: Enhancing Patient Access in the Orphan Drug Landscape

    11:20